Target intelligence / Profile preview

Keratin and other disulfide bond–containing structural proteins

Molecular classification
Structural protein, Intermediate filament
01

Overview

Keratins are a diverse group of intermediate filament proteins that provide essential mechanical support and structural integrity to epithelial tissues, including the skin, hair, and nails (Bragulla & Homberger, 2009). These proteins are characterized by a high concentration of cysteine residues, which facilitate the formation of extensive inter-chain disulfide bonds, resulting in a tough, insoluble, and chemically resistant matrix (NCBI, 2023). In pharmacology, these disulfide-rich structures are targeted by reducing agents, such as thioglycolic acid, which break the S-S bonds to allow for the physical reshaping of hair (PubChem). Keratolytic agents like salicylic acid and urea are used to treat hyperkeratotic disorders by disrupting the cohesion between keratinocytes, thereby promoting the shedding of the stratum corneum (StatPearls, 2023). Additionally, the keratophilic nature of certain antifungal drugs, such as terbinafine and griseofulvin, allows them to accumulate in keratinized tissues, making them effective against dermatophyte infections (Gupta et al., 2012). Mutations in specific keratin genes are associated with various genetic diseases, such as epidermolysis bullosa simplex, where the loss of structural support leads to severe tissue fragility (UniProt).

Other names
CytokeratinIntermediate filament proteinsS-S bonded structural proteinsCornified envelope proteins
02

Mechanism of action

Reduction of disulfide bonds (cleaving S-S to -SH), disruption of non-covalent protein-protein interactions (keratolysis), and high-affinity sequestration/binding by keratophilic agents.

03

Biological functions

Structural integrityBarrier functionMechanical protectionCellular scaffoldingEpithelial resilience
04

Disease associations

PsoriasisIchthyosisOnychomycosisEpidermolysis bullosaKeratosis pilarisPachyonychia congenita
05

Safety considerations

Contact dermatitisChemical burnsSkin irritationSkin barrier disruptionSystemic absorption of thiols
06

Interacting drugs

Thioglycolic acid

7 more in the full profile.

07

Biomarkers

Cytokeratin 18 (KRT18)Cytokeratin 19 (KRT19)Caspase-cleaved cytokeratin 18 (M30)Tissue Polypeptide Antigen (TPA)

Beyond the preview

Go deeper on Keratin and other disulfide bond–containing structural proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin and other disulfide bond–containing structural proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call